Afya (NASDAQ:AFYA) Share Price Breaks Below 200 Day Moving Average – Time to Sell?

Afya Limited (NASDAQ:AFYA)’s share price passed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $14.31 and traded as low as $10.05. Afya shares last traded at $10.64, with a volume of 1,768,506 shares.

Analysts Set New Price Targets

AFYA has been the subject of several analyst reports. JPMorgan Chase & Co. upgraded shares of Afya from a “neutral” rating to an “overweight” rating and dropped their target price for the company from $21.00 to $19.00 in a research report on Wednesday, October 7th. Bradesco Corretora raised shares of Afya to an “outperform” rating and set a $17.00 price target for the company in a report on Thursday, September 24th. Zacks Research upgraded shares of Afya from a “strong sell” rating to a “hold” rating in a research report on Monday, October 5th. Wall Street Zen raised shares of Afya from a “hold” rating to a “buy” rating in a research note on Saturday, September 5th. Finally, Weiss Ratings cut shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Two investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $17.25.

Afya Price Performance

The business has a 50-day moving average of $13.77 and a two-hundred day moving average of $14.24. The firm has a market cap of $959.72 million, a P/E ratio of 6.24, a price-to-earnings-growth ratio of 1.83 and a beta of 0.34. The company has a current ratio of 2.20, a quick ratio of 2.20 and a debt-to-equity ratio of 0.39.

Afya (NASDAQ:AFYA) last released its quarterly earnings data on Friday, August 14th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. The company had revenue of $187.80 million during the quarter, compared to the consensus estimate of $189.62 million. Afya had a return on equity of 17.58% and a net margin of 20.55%. On average, sell-side analysts anticipate that Afya Limited will post 1.72 earnings per share for the current fiscal year.

Insider Transactions at Afya

In other news, insider Santos Welder Ferreira sold 4,161 shares of the firm’s stock in a transaction on Monday, October 5th. The shares were sold at an average price of $13.30, for a total transaction of $55,341.30. Following the completion of the transaction, the insider owned 35,000 shares of the company’s stock, valued at approximately $465,500. This trade represents a 10.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Institutional Trading of Afya

A hedge fund recently bought a new stake in Afya stock. Public Employees Retirement System of Ohio bought a new position in shares of Afya Limited (NASDAQ:AFYA) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 4,500 shares of the company’s stock, valued at approximately $67,000. Institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.

Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.

The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.